Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 10/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | RET | P07949 | 2/20 | 0.36 |
| ▸ | TIPARP | Q7Z3E1 | 1/20 | 0.36 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.34 |
| ▸ | BRAF | P15056 | 2/20 | 0.34 |
| ▸ | KDR | P35968 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2120861 | 0.92 | AR (0.44) | ARTRPA1MAPT | |
| SCHEMBL2617885 | 0.92 | AR (0.52) | ARTRPA1TIPARP | |
| SCHEMBL2617817 | 0.92 | AR (0.52) | ARTRPA1TIPARP | |
| SCHEMBL2617818 | 0.92 | AR (0.44) | ARTRPA1MAPT | |
| SCHEMBL2120737 | 0.92 | AR (0.52) | ARTRPA1TIPARP | |
| SCHEMBL2617881 | 0.92 | AR (0.44) | ARTRPA1MAPT | |
| SCHEMBL2617876 | 0.91 | AR (0.43) | ARTRPA1TIPARP | |
| SCHEMBL2617819 | 0.91 | AR (0.43) | ARTRPA1TIPARP | |
| SCHEMBL2119055 | 0.91 | AR (0.43) | ARTRPA1TIPARP | |
| SCHEMBL2617878 | 0.84 | AR (0.44) | ARTRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120094981-A1 | ANTHELMINTIC AGENTS AND THEIR USE | INTERVET INTERNATIONAL B.V. (NL) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120094981-A1 | ANTHELMINTIC AGENTS AND THEIR USE | ABCB11, ACHE, CMA1 | AR 4346/4885TRPA1 530/4885RET 4682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.